Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Andrew Robert Branagan, Ph.D., M.D.

Concepts (194)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Andrew Branagan's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Andrew Branagan has written about over time.
Antibodies, Monoclonal, 12 publications between 2003 and 2020, average publication date September 2007. Antineoplastic Agents, 10 publications between 2003 and 2021, average publication date January 2010. Waldenstrom Macroglobulinemia, 36 publications between 2003 and 2022, average publication date December 2011. Thalidomide, 3 publications between 2008 and 2021, average publication date December 2012. Immunization, Secondary, 1 publications between 2017 and 2017, average publication date March 2017. Paraproteinemias, 2 publications between 2016 and 2021, average publication date August 2018. Influenza Vaccines, 2 publications between 2017 and 2021, average publication date March 2019. Influenza, Human, 2 publications between 2017 and 2021, average publication date March 2019. Multiple Myeloma, 11 publications between 2016 and 2022, average publication date February 2020. SOXB1 Transcription Factors, 1 publications between 2021 and 2021, average publication date February 2021. Point Mutation, 2 publications between 2021 and 2021, average publication date April 2021. Receptors, CXCR4, 5 publications between 2020 and 2021, average publication date April 2021. Myeloid Differentiation Factor 88, 6 publications between 2020 and 2022, average publication date July 2021. Protein Kinase Inhibitors, 5 publications between 2020 and 2022, average publication date August 2021. Adenine, 5 publications between 2020 and 2022, average publication date September 2021. Piperidines, 6 publications between 2020 and 2022, average publication date October 2021. Lymphoma, B-Cell, 2 publications between 2022 and 2022, average publication date May 2022. Granulocyte Colony-Stimulating Factor, 1 publications between 2022 and 2022, average publication date October 2022.

To see the data from this visualization as text, click here.
Branagan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (194)
Explore
_
Co-Authors (37)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.